Carvalho-Filho, Roberto J.

Publishing since 2005 (Baby)

Has published 9 publications in 6 years

Number of publications published per year by Carvalho-Filho, Roberto J.. (Source : PubMed)

Distribution of publications types for Carvalho-Filho, Roberto J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Cardoso AC, Moucari R, Figueiredo-Mendes C, Ripault MP, Giuily N, Castelnau C, Boyer N, Asselah T, Martinot-Peignoux M, Maylin S, Carvalho-Filho RJ, Valla D, Bedossa P, Marcellin P. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis.  J. Hepatol.  2010  
•  Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Medina-Pestana JO, Lanzoni VP, Ferraz ML, Silva AE. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.  Scand. J. Gastroenterol.  2010  
•  Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Pinheiro SR, Barbosa DV, Lanzoni VP, Ferraz ML, Silva AE. Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.  J. Viral Hepat.  2009  
•  Carvalho-Filho RJ, de Lucca Schiavon L, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Gomes Ferraz ML, Benedito Silva AE. Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C.  Liver Int.  2009;29;1  
•  Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Cardoso JR, Freire FC, Sampaio JP, Bordin JO, Soares MA, Silva AE, Ferraz ML. Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results.  Eur J Gastroenterol Hepatol  2008;20;11  
•  Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Barbosa DV, Lanzoni VP, Ferraz ML, Silva AE. Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.  Hepatology  2008;48;1  
•  Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Freire FC, Cardoso JR, Bordin JO, Silva AE, Ferraz ML. Anti-hepatitis C virus-positive blood donors: are women any different?  Transfus Med  2008;18;3  
•  Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.  Liver Int.  2008;28;4  
•  Rocha CM, Perez RM, Ferreira AP, Carvalho-Filho RJ, Pace FH, Silva IS, Pestana JO, Lanzoni VP, Silva AE, Ferraz ML. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.  Liver Int.  2006;26;3  

[ See timeline ] [ See all publications ]